R&D
Brighter future, by specialized research.

WLHF-002(Goalflex®)

Degenerative joint disease

WLHF-002(Goalflex®) is a new natural product that can help degenerative arthritis.

Background
Degenerative joint disease, which is also referred to as osteoarthritis, is the highest incidence of inflammatory diseases in joints.
Disordering joints can cause damage to cartilage, bones, and ligaments, causing pain and inflammation.
  • Degenerative joint disease of type and risk factors
    국제암연구소(IARC)에 따른 발암물질 분류
    Degenerative joint disease of type Risk factors
    Idiopathic arthritis
    (Primary arthritis)    		 age, sex, genetics, obesity and specialty joints parts etc.
    Continuous arthritis
    (Secondary arthritis)    		 factors such as trauma, deformity and disease caused by articular cartilage damage
  • Number of degenerative arthritis patients (2016) Reference : Health Insurance Review & Assessment Service
Progress of degenerative arthritis
  • Early stage
  • Middle stage
  • Late stage
As of 2017, there were approximately 3.76 million degenerative arthritis cases, with 1 in 3 people aged 65 older having degenerative arthritis.
Efficacy evaluation of WLHF-002(Goalflex®)

  • WLHF-002(Goalflex®) significantly reduces
    articular cartilage damage.

  • WLHF-002(Goalflex®)reduces pain caused by
    arthritis and makes movement easier.

  • WLHF-002(Goalflex®) reduces inflammation
    caused by arthritis.

    ※ TNF-α (Tumor Necrosis Factor Alpha):
    The primary role of TNF is in the regulation of immune cells.

    ※ IL-1β (Interleukin 1 beta):
    This cytokine is an important mediator of the inflammatory response.

    ※ IL-6 (Interleukin 6):
    The signal transmission by JAK/STAT signaling pathway related to chronic inflammatory diseases